Nsn Foundation Inc
- Assets
- $81.3m
- Revenue
- $3.4m
- Investments
- $0.0
- Employees
- 0
- Location
- Roseland, NJ
- Founding
- 03/2001
- Data as of
- 11/2023
- EIN
- 22-3769097
Organization Overview
Nsn Foundation Inc is located in Roseland, NJ. The organization was established in 2001. According to its NTEE Classification (T21) the organization is classified as: Corporate Foundations, under the broad grouping of Philanthropy, Voluntarism & Grantmaking Foundations and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Nsn Foundation Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 11/2023, Nsn Foundation Inc generated $3.4m in total revenue. This represents a relatively dramatic decline in revenue. Over the past 4 years, the organization has seen revenues fall by an average of (43.6%) each year. All expenses for the organization totaled $420.0m during the year ending 11/2023. You can explore the organizations financials more deeply in the financial statements section below.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
John L Berger Vice President/asst Secy. | 0.1 | $0 | |
Kenneth J Slutsky President/treasurer | 0.1 | $0 | |
David Mills Vice President/secy. | 0.1 | $0 | |
Nison Mangement Llc Member | 0.2 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Contributions, Gifts, Grants & Similar | $0 |
| Interest on Savings | $1,218,515 |
| Dividends & Interest | $2,229,036 |
| Net Rental Income | $0 |
| Net Gain on Sale of Assets | $0 |
| Capital Gain Net Income | $0 |
| Net ST Capital Gain | $0 |
| Income Modifications | $0 |
| Profit on Inventory Sales | $0 |
| Other Income | $0 |
| Total Revenue | $3,447,551 |
| Statement of Expenses | |
|---|---|
| Compensation of officers, directors, trustees, etc | $0 |
| Other employee salaries and wages | $0 |
| Pension plans, employee benefits | $0 |
| Interest | $0 |
| Taxes | $47,182 |
| Depreciation | $0 |
| Occupancy | $0 |
| Travel, conferences, and meetings | $0 |
| Printing and publications | $0 |
| Other expenses | $23,169 |
| Total operating and administrative expenses | $100,351 |
| Contributions, gifts, grants paid | $419,861,396 |
| Total expenses and disbursements | $419,961,747 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $415 |
| Savings and temporary cash investments | $80,869,754 |
| Net Accounts receivable | $0 |
| Net Pledges Receivable | $0 |
| Grants receivable | $0 |
| Receivables from Officers, Directors, or Controlling Persons | $0 |
| Net other notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $157,885 |
| Net Investments - land, buildings, equipment | $0 |
| Investments—mortgage loans | $0 |
| Investments—other | $0 |
| Net Land, buildings, and equipment | $0 |
| Other assets | $248,757 |
| Total assets | $81,276,811 |
| Accounts payable and accrued expenses | $0 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Mortgages and other notes payable | $0 |
| Other liabilities | $7,666 |
| Total liabilities | $7,666 |
Grants Awarded
Over the last fiscal year, Nsn Foundation Inc has awarded $419,861,396 in support to 3 organizations.
| Grant Recipient | Amount |
|---|---|
CHDI FOUNDATION INC ATTN KEN SLUTSKY TAX EXEMPT INST GRP PURPOSE: TO FURTHER CHDI'S DIRECT CHARITABLE ACTIVITIES OF PROMOTING AND ASSISTING IN MEDICAL AND SCIENTIFIC RESEARCH IN THE FIELD OF NEURODEGENERATIVE DISEASES. | $245,447,724 |
JEWISH COMMUNAL FUND PURPOSE: FOR THE GENERAL FUND OF THE CHARITY | $47,500,000 |
HIGH Q FOUNDATION INC ATTN KEN SLUTSKY TAX EXEMPT INST GRP PURPOSE: TO INCREASE THE CHARITABLE ENDOWMENT WHICH SHALL SERVE AS A PHILANTHROPIC FUND FOR THE PRIMARY PURPOSE OF SUPPORTING SUITABLE CLINICAL TRIALS. | $126,913,672 |